US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
NH

NH.NS

$1869.20
Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-26
🕌 BSE 500 Shariah HTR non-permissible income 0.76%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Narayana Hrudayalaya Limited (NH.NS) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$2213.07
+18.4% · 14 analysts
Institutional own.
12.8%
of shares
COMPLIANT
Sharia compliance
🕌 BSE 500 Shariah
Constituent of a real Sharia index
0.76%
Non-permissible income — HTR, from filings (2026-03-31)
$2213.07
Price target (+18.4%) · 14 analysts
12.8%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2026-03-31. NH.NS files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 18.22% 30.00% Pass
Interest-bearing investments 6.74% 30.00% Pass
Non-permissible income 0.76% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 54.90% 33.00% Fail
Interest-bearing investments 20.31% 33.00% Pass
Non-liquid assets 74.44% at least 20.00% Pass
Non-permissible income 0.76% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 54.90% 33.33% Fail
Cash + interest-bearing securities 20.31% 33.33% Pass
Accounts receivable 25.56% 33.33% Pass
Non-permissible income 0.76% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 54.90% 33.33% Fail
Cash + interest-bearing securities 20.31% 33.33% Pass
Accounts receivable 25.56% 50.00% Pass
Non-permissible income 0.76% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 20.06% 33.00% Pass
Cash + interest-bearing securities 7.42% 33.00% Pass
Accounts receivable 1.92% 33.00% Pass
Non-permissible income 0.76% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 22.24% 33.00% Pass
Cash + interest-bearing securities 8.23% 49.00% Pass
Accounts receivable 2.13% 49.00% Pass
Non-permissible income 0.76% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 22.24% 33.33% Pass
Cash + interest-bearing securities 8.23% 33.33% Pass
Accounts receivable 10.36% 49.00% Pass
Non-permissible income 0.76% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

2,080.301,960.661,841.021,721.391,601.752025-09-112026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1848.13
S2
1864.57
S1
1887.13
PIVOT
1903.57
R1
1926.13
R2
1942.57
R3
1965.13

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
1828.55 2016.85
±4.9% from 1922.7, made 2026-09-02 · resolves 2026-09-09
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22052 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSTRONG SELL
1 buy · 4 neutral · 2 sell
Moving averagesSTRONG SELL
2 buy · 0 neutral · 10 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)46.10NEUTRAL
Stochastic %K (14)35.58NEUTRAL
CCI (20)14.15NEUTRAL
Williams %R (14)-64.42NEUTRAL
MACD (12,26,9)3.98BUY
ROC (10)-1.82SELL
Momentum (10)-34.60SELL
EMA (10)1888.99SELL
SMA (10)1900.83SELL
EMA (20)1889.47SELL
SMA (20)1870.48SELL
EMA (30)1895.32SELL
SMA (30)1876.56SELL
EMA (50)1901.98SELL
SMA (50)1932.32SELL
EMA (100)1891.45SELL
SMA (100)1904.28SELL
EMA (200)1862.08BUY
SMA (200)1855.47BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Narayana Hrudayalaya Limited

Healthcare · Medical Care Facilities

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, uro oncology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

narayanahealth.org ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.